GTII

sdkiko

I love getting +10% alerts for GTII. Impossible to know which way until I open the email. Nice surprise today.

N0-name1

I’ve been in cannabis on and off since the 2017 Canopy days, and it still blows my mind how we can drop 30% on no news. Now it feels like another mountain just to get back to where we were on Thursday. Honestly, at this point I’d love to see GTII or TRUL just get bought out and go private—the market is completely irrational

sdkiko

Bought another 625 shares of GTII @ 7.98 CAD. 2731 shares total :)

infinite_cura

Just buy GTII and forget about it for 10 years.

Equivalent_Smell_325

I saw GTII and knew you were fine. In a sector this cluttered, there are only a few names I’m sure will make it to the next election, and GTII is 100% one of them

sdkiko

Sending another 5k to the RRSP for more GTII

infinite_cura

WEED and TLRY bitching for the Red. CRESCO weeping, thinking down only 3% is a blessing. TRUL and GTII: WTF... That's like nothing. CURA enters the room...

Turbul

Buying GTII under 9 CAD again almost feels criminal..

the_mammynun

Good points however I'll believe it when I see it regarding Senorita. GTII hasn't made one brand successful to date, nothing as explosive as brands like Wyld gummies or Wana.

the_mammynun

RYM is a shell company that owns nothing except GTII brands...so owning RYM does not add any new value. It's the same brands they owned before just in a new vehicle.

Turbul

If GTII drops into the $7–8 CAD range, I’ll be adding heavily to my position.

MegaDriveCDX

I didn't even know about the dilution. Fuck me for not doing my due diligence. I'm still in the green despite losing a shit ton at it's peak but I'm out next week. I went through this shit with amc, GTII, and loads of other stocks.

No_Love_Gained

My moves include additions to Tsnd, CL, and reentry into OGI. My order for GTII didn't fill, and I'll see if that works out next week. Glta

UsedState7381

GTII and CURLF have to be following next up or otherwise this is grade A bullshit.

Conor__K

ACB most likely. CURA, GTII etc have high valuations already

martyd94

Wanted to buy more GTII but didn't hit my 12cad limit.

StarMaker7

No, there is nothing wrong with GTII. It seems some traders/investors are taking some profit at EOD, fearing a dump tomorrow. All things seem normal.

Pixel_Mason

Hey guys I noticed GTII is lagging behind today. What is the scoop? Bad news or something?

JohnnnyOnTheSpot

GTII selling into the close is crazy work

No_Love_Gained

CWEB, HITI (they own 2 DTC CBD brands in the US), and GTII will be my play.

the_mammynun

HITI (all canna retail) definitely has an existential threat in the US. Though I feel its current models in Canada and Europe are sustainable for the next 10 years. You're right, I'm not only picking on GTII but all MSOs. Honestly I think farming operations are just the wrong way to invest in this industry. And like you said, even retail has a major threat, especially in the US. 

the_mammynun

GTII is the best in a sector with god-awful fundamentals. Every single MSO is at risk of bankruptcy because of the prohibition era structure they've spent years and billions of dollars investing in.  At least GTII has had ~10% revenue CGAR over the past 4 years and net profits have remained flat. They pay their debt and buy back shares. Financially, they're well managed. Unfortunately they have a terrible model that can't last forever.

the_mammynun

Totally, it's a fair point. I haven't liked GTIIs principle assets for a few years now. They aren't particularly strong in retail growth, and they will never win in production with their prohibition era network of grow ops. I'd value their brands at about $200m USD today and I feel that's generous considering their position. Therefore I would buy RYM at a discount, but I have no interest in GTII.

the_mammynun

I still believe GTII becomes irrelevant, but at least shareholders will own a piece of Agrify in the end. Ben's not leaving them behind entirely.

the_mammynun

Hey buddy we're all here to discuss and learn. I don't invest in GTII or RYM but I know a lot about GTIIs history. Just last week I informed actual RYM shareholders that the market cap was $600m, not $75m. 

N0-name1

GTII

the_mammynun

You do realize these are separate companies right?  Agrify took the best assets, and the CEOs attention. These two companies will never merge. Rythm has the superior structure and GTIIs assets would only slow them down. GTII has been reduced to a prohibition era patchwork of grow ops and dispensaries, with a distracted CEO. 

TroubledAcorn

Its not rip GTII, its a good thing for GTII

the_mammynun

RIP GTII, Ben is fully invested here and also just made 20x his money on the stock. It's a better model, too.

martyd94

I'm not buying at this time, but if GTII retraces back down to 8.50CAD and under then I got no choice than to buy.

Loose-Dream7901

I’d balance safety and return so any of the top guys GTII, CURA, TRUL easily the top guys that will lead any ETFs. The rest are a tier down.

HugeDramatic

Incase anyone is curious I asked Grok 4 Expert why the next two largest MSOs haven’t uplisted from the CSE to the TSX: Trulieve Cannabis (CSE: TRUL; OTC: TCNNF) and Green Thumb Industries (CSE: GTII; OTC: GTBIF) have not uplisted to the Toronto Stock Exchange (TSX) primarily due to strategic priorities, regulatory complexities, and perceived limited benefits compared to potential future U.S. exchange listings. 97 107 108 Both companies, as U.S.-based multistate operators (MSOs) in the cannabis sector, face unique challenges stemming from federal illegality in the U.S., which complicates listings on major exchanges. Key Reasons: • Focus on Potential U.S. Exchange Uplisting: Many MSOs, including Trulieve and Green Thumb, are prioritizing federal cannabis rescheduling (e.g., moving to Schedule III), which could eliminate punitive 280E taxes and enable direct listings on U.S. exchanges like NASDAQ or NYSE. 7 30 76 62 This would offer greater liquidity, higher valuations, and broader institutional access than the TSX. Rescheduling progress (e.g., HHS recommendations and ongoing DEA reviews) has fueled optimism, making a TSX move seem like an unnecessary interim step. 96 94 For instance, Trulieve filed a shelf registration in June 2025 with no immediate plans for offerings, signaling preparation for U.S. opportunities rather than TSX. 83 • Higher Costs and Complexity of TSX Uplisting: Listing on the TSX is more expensive and rigorous than remaining on the Canadian Securities Exchange (CSE), where both companies currently trade. 107 It often requires raising capital (e.g., Curaleaf raised CA$16 million in 2023 to meet TSX float requirements) and complex restructuring, such as ring-fencing U.S. plant-touching assets to comply with legal concerns. 79 81 107 This could involve dilution, which both companies may want to avoid—Green Thumb announced a $50 million share repurchase program in 2024, focusing on returning value to shareholders instead. 73 Auditor sign-off on consolidated financials including U.S. operations remains uncertain due to federal risks. 107 • Limited Perceived Benefits: While the TSX offers better visibility and potential index inclusion (e.g., S&P/TSX Composite), experiences like Curaleaf’s suggest it may not significantly boost institutional investment or valuations due to share structures and ongoing U.S. federal stigma. 2 105 108 98 Trulieve and Green Thumb, with strong operational focus (e.g., expansions in Florida and Ohio), may see staying on CSE/OTC as sufficient for now, especially with comparable market caps to Curaleaf (~C$2 billion each). 12 6 • Market and Regulatory Caution: The TSX has been receptive to cannabis firms, but U.S. MSOs must navigate TMX Group policies on U.S. operations. 80 1 61 With events like Florida’s failed adult-use legalization in 2024 impacting sector sentiment, companies like Trulieve (heavily Florida-exposed) are prioritizing cash flow and operations over exchange upgrades. 4 95 Overall, while not explicitly stated by the companies, analyst commentary and industry trends indicate these MSOs view TSX uplisting as a lower-priority move amid hopes for U.S. reforms. 97 102 If rescheduling stalls, they could reconsider, as seen with Curaleaf in 2023. 86

ApostleThirteen

So taking into account these kinda HUGE numbers that definitely affect what is the "Bottom Line" of some of these companies, is that even if getting Schedule 3 occurred, and these companies were allowed to uplist based only on that, most (aside from GTII) would be forced to either "render unto Caesar", or try to fight it in court, possibly for YEARS before being allowed to uplist.

the_mammynun

Green Thumb has taken a cautious approach to retail, growing by just 5-10 stores per year in the last few years. They seem indecisive as to if they see a future as a retailer. They are equally a CPG company and a grower, so their attention is split between 3 major businesses. High Tide opens 25-30 stores per year. They are real estate experts and the majority of their think-tank is spent considering how to improve store economics while capturing market share as a discount retailer. They are 100% recreational and have a unified design so customers know what to expect. Green Thumbs stores can vary state-to-state, depending on if it's rec or medical. Sometimes it's a counter/waiting room style, and sometimes recreational.  Essentially, HITI is a better retailer. They've chosen to focus on one thing and to do that thing really well. Whether that strategy works in the United States depends on if cannabis is allowed to be sold at gas stations or liquor stores. In that case CPG companies will take center stage. This is potentially why GTII has been cautious in retail rollout.

bananastock

Second part. Low float, obviously a strategy behind moving brands to it. I imagine GTII being the low margin grower/retailer and RYTM being the high margin brand portfolio. Kinda like NVDIA designs the products but TSM makes the product.

the_mammynun

I disagree. HITI has an operational structure that is built to last. Green Thumb's state patchwork of grow facilities and dispensaries (sometimes less than 10 in a state, just over 100 total) gives them virtually no economic moat. Once interstate commerce opens up their grow-ops will become worthless due to rapid price compression, and other "retail-first" companies will outpace them in dispensary buildout.  Green thumbs saving grace was their brands (which aren't even performing exceptionally well) and they just sold them all to Agrify. Mark my words, Ben and other insiders will shift their attention to Agrify and leave GTII in the dust. It was set up too early, and they know it's not future proof. That's why they took control of Agrify and shifted their best assets their.

Cool_Ad_5101

I also think that’s smart. GTII is the safest play in this high risk space

Ok_Obligation_2142

Any reason GTII bids up premarket,

the_mammynun

Just so everyone understands, Agrify (Rythym) is now a $750m USD shell company that GTII leadership is transfering their time and energy to. I would not be surprised to see Ben step down from GTII and focus entirely on this. He has always known the future was in brands, not in an outdated patchwork of dispensaries and grow operations. I still think Rythym is overvalued considering they are a new entrant and have rallied 1500% in the past year, but the structure has potential to benefit from reform. Ben really played investors here. GTII will be left in the dust and meanwhile Ben and leadership got rich on Agrify stock.

the_mammynun

My take is GTI knows it's operational structure is trash and won't ever be acquirable or scalable so they are moving their more future-proof assets (brands) to a new vessel which can have a fresh start and more potential for scale/M&A than the current patchwork of growops and dispensaries under GTII. I think GTII, and all MSOs become uninvestable after interstate commerce begins.

Humungusminimaglight

All of a sudden GTII is now my bigglest position, just overtook VFF.

sdkiko

Continuing to hold GTII

sdkiko

Please remember that GTII owns Agrify/Rythm and they have the right to transform 50 million into shares @ $29. Do what you will with that information.

Ok_Obligation_2142

Suck a sick joke with GTII

200cents

whats going on with GTII this should be the best performer

Prabha11

Is this good for GTII or not? Lol no one has a clue

NaturallyZen

Yeah, it’s quite the inner conflict. Play it safe with GTII or go for the gains with some of the other MSOs

Lebempe

That is the tradeoff. GTII is the best stock on the sector so it will remain more conservative when prices go up as well as when they go down.

NaturallyZen

I’ve been accumulating a large amount of GTII as well for the same reason, but a part of me wonders if I’m going to miss a part of the run up because it’s relatively underperforming. Quite the dilemma lol

Cool_Ad_5101

Yep I wish GTII held that .40 cent gain too. But whatever let’s just get this fooking announcement and then onto uplisting, safer and hemp loophole closure 

N0-name1

GTII

Kbarbs4421

> they may be running into issues with swap providers causing the selling of GTII. If they were, they wouldn't admit it. Why not? Genuine question. I'm way out of my depth when it comes to swap structure. > What is really strange is stopping quarterly earnings calls. Even if you feel it's a waste of time, you do it because the shareholders want to hear from you. Hear hear. Couldn't agree more. Really bad look.

bananastock

We can't know. He might be right. He might be bitter CRUA weasled their way onto TSX. He might be making a big deal out of something small. Unless you're an expert in capital markets, you can't make a knowledgeable decision. I've been in capital markets for 15 years and it was a challenge to understand how all the nitty gritty details of the swap structure worked. Just when I thought I knew, I discovered more nuance around the difficulties of the structure. You have to give it to advisor shares, the forged the way with a creative structure even if it's not perfect. And, they may be running into issues with swap providers causing the selling of GTII. If they were, they wouldn't admit it. What is really strange is stopping quarterly earnings calls. Even if you feel it's a waste of time, you do it because the shareholders want to hear from you. But, we don't know his motivation.

the_mammynun

It's that High Tide has an operational structure that is built to last. They have grown the strongest federally legal retail brand in existence, in a highly competitive environment. If you can compete in Canada you can compete anywhere. Green thumb and Trulieve are decent companies, and definitely have more exposure to the US. But their operational structure is trash, and all institutional investors recognize this. Nobody wants to invest in a company that has a patchwork of farming operations in every state where they operate retail stores. It's messy and inefficient. Long term the US will have three categories of weed companies and only two of them will be investable. 1) Pure play large scale farmers (Not investable) 2) Pure Play CPG Companies (Investable) 3) Pure Play Retailers. (Investable) It's one thing to invest in Maxwell House (CPG) or Starbucks (Retail) but who in their right mind would invest in the company that grows the beans? It's a commodity and it's simply too competitive/low margin. High Tide has the winning model, and they intend to bring it to the US once the NASDAQ allows it. They focus purely on retail and even develop their own CPG brands without growing a single gram of cannabis. They've eliminated all of the messy aspects of the MSO model and give investors exactly what they asked for.. the Starbucks of weed. The only way MSOs like GTII or TRUL will survive in an interstate commerce environment is to sell off their grow operations and get focussed on what matters. Brands, and/or the best retail locations. 

Healthy_Equipment523

Always glad to be able to average up GTII at these prices, a great opportunity!

Healthy_Equipment523

Great opportunity to buy GTII cheap tomorrow morning, hope this doesn't gap up so I can buy

NaturallyZen

Someone has to explain wtf is happening with the buying/selling of MSOs by the ETF. Selling GTII and TRUL for lower tiers? And why the absolute fuck are they hoarding cash now when they were fine having a negative cash balance only just a few weeks ago?!

martyd94

Sold all ym cresco and gtii in my one account. Paid off my debt. Now riding 650 shares of GTII left.

Cool_Ad_5101

I’m in for the long term. I think GTII and trulieve will be two of the winners 

NaturallyZen

Just blew my entire load on GTII and CL, see you next Monday guys. Hopeful things go up from here, maybe even something spicy over the weekend to give us the next leg up

UsedState7381

Yes, when the price of holdings goes up like that, it does throws the weightings around like that. If we keep going up like this, soon enough CURA will be the biggest holding in the ETF, considering that the ETF is priorizing it over the other names. It does have to be said though: in the event of another rug pull followed by a downward trend, I would expect GTII to be the biggest holding again, as it will be the stock losing the least of them all.

NaturallyZen

I'm all for TRUL, and CURA is okay too, but make it make sense! I'm gonna have to do some rebalancing, refinance my mortgage, and go all in on GTII if this keeps up LOL Goddamn...

NaturallyZen

HOLD UP TRUL and CURA now have a higher weighting than GTII in $MSOS??! No words...wow.

NaturallyZen

I won't be surprised if other T1s like CURA and TRUL have caught up to GTII due to appreciating more than GTII this past week or so. And if that is the case, GTII no longer being #1 will be something to behold.

Cool_Ad_5101

GTII is the best if you are green in Verano 

NaturallyZen

really hope MSOS is not selling GTII again for some tier 3 shit

GLGTraumaVictim

Curious what avgs other bagholders (or non bag-holders) are working with right now. Here's mine (these are for CAD tickers FYI): 13.8 for GTII 5.3 for Canopy 5.8 for Cresco Not teeeerrible if things run here. I'm hoping for a pullback before moon mode so I can start a Trulieve position.

UsedState7381

Bruh, GTII is up almost 8% today

GLGTraumaVictim

My average for GTII is in the 13s (CAD version, which SP is currently 11.86)

GLGTraumaVictim

What's the better play here if Trump actually reschedules in the next month? GTII or Trulieve? I know GTII is more profitable but the latter's Florida connection seems hard to ignore. I have 300 shares of GTII already but am considering starting a Trulieve position. Should I just keep buying the former?

NaturallyZen

Scooped up a ton of GTII, now LFGGG

Cool_Ad_5101

I was looking into Reddit. But no money :( I think GTII gets back there. Will hit 20 on reschedule imo and then good results will help it longer term 

ApostleThirteen

The average age of GTII board members is 48 y.o. The YOUNGEST "Boomer" you'll meet is 60 y.o. That isn't paint on that brush you're using on everything.

Cool_Ad_5101

if GTII moons then definitely pull some out for safer pastures. hope it does for everyone’s sake. 60,000 shares is a good good stake.

Cool_Ad_5101

I agree in this case. I would never put 100% of total portfolio in cannabis but 100% of cannabis portion in GTII is smart IMO. I am around 50% GTII 43% trulieve and 7% cresco as I like bachtell as ceo. but I would be happy with 100% in green thumb.

NaturallyZen

GTII is gonna get all my TLC first thing tomorrow

123_holden

Haven't been keeping track of my weed stocks(still holding GTII, TRUL & TLRY). Been concentrating on my growing my kid's RESP account given how expensive Uni is. But it is nice to see a day like this. Any reason why GTII is lagging... up 20% while others reached 30 to 40%?

GLGTraumaVictim

Haven't been here in a while or kept up to date on the MSOs. What's the best play going forward here out of GTII, Cresco, and Cure?

NaturallyZen

Nice recovery from GTII

Tiaan

> I'm willing to believe that it's just someone, or a bunch of people, making a very large bet that reform is coming...But how can we be sure of that? I don't know what you mean? 11 trading days of consistent inflows totaling nearly $60M is not something that some random twitter pump group can do. Clearly someone or a group with big pockets is consistently buying MSOS for some reason. Who knows what the reason is but generally people buy when they believe the stocks will be worth more in the future Ben already said he's not going private unless GTII stock keeps getting consistently manipulated lower. I don't think he's taking the company private anytime soon

UsedState7381

>The real question is why we've gotten inflows for the past 10 trading days (likely 11 today) in a row if nothing was actually happening behind the scenes I'm willing to believe that it's just someone, or a bunch of people, making a very large bet that reform is coming...But how can we be sure of that? Or maybe it's just seasonal rotation into microcaps, MSOS is still vaguely following IWM after all. I don't know, just spitballing here, but now I'm very concerned about what happens to GTII. I don't think that Ben would be cold-hearted enough to get the company private again before S3, it doesn't make financial sense either.

UsedState7381

We already got a reality check, GTII wanting to get out of the public market because it's not finding value here is telling enough for those paying attention.

UsedState7381

Okay....If this materializes before S3 final rule, I'm dropping MSOS ASAP because GTII and S3 are literally the only reasons why I still hold it. And I have a sneaking suspicion that this leaked to the public before market open today, which explains the dump. I knew something was off this time. Hell, I might not even wait to see if this is real because frankly, MSOS without GTII is worthless.

UsedState7381

Bruh, who's dumping GTII right before the earnings tomorrow? Red herring?

KAESLAX

Been an interesting year for the LPs - first time many of them are (just barely) posting FCF positive for the year, and both CRON and ACB have positive profit margins as well. Cash flows look much better for the MSOs, but GTII still the only one posting positive profit margins.

bananastock

Only 3 investable companies. CRON, SNDL and GTII.

NaturallyZen

GTII gonna carry us to the promise land 🙏🏽

OwnPomegranate1932

GTII just got nuked

martyd94

Yup I started doing that last year. Got my bag positions on CL and GTII and now waiting to buy back in one GTII under 8 maybe 7.5 which I sold at 8.8 past week. Trying to get my average down through swing trades and accumulating. Lol

martyd94

Come on, bring GTII under 8cad. I'll play this game again.

Den923

I think value now should be close to 30$ . Once all of the following are in place who knows...80$? **Green Thumb Industries (GTII) – Investment Highlights** * **Strong Fundamentals Amid Market Lows** * GTII stands out in a struggling cannabis sector due to its solid financial health and strategic growth initiatives. * **Operational Efficiency & Market Expansion** * Demonstrates strong performance through disciplined operations and a growing footprint across multiple states. * Actively diversifying into new product categories, strengthening long-term growth potential. * **Attractive Acquisition Target with Independent Strength** * Seen as a prime takeover candidate, yet its standalone prospects remain compelling—especially for investors willing to tolerate risk. * **Regulatory Tailwinds Enhance Outlook** * DEA likely to reschedule cannabis to Schedule III in 2025, reducing tax burdens (notably 280E) and increasing MSO profitability. * Expected reintroduction of the SAFER Banking Act, States Reform Act, and STATES 2.0 Act in 2025 could improve banking access and federal legitimacy for cannabis operators. * New hemp regulations may suppress illicit competition, benefiting compliant players like GTII. * **Strategic Partnerships Accelerate Growth** * A potential co-location deal with Alimentation Couche-Tard (7-Eleven) could significantly expand GTII’s retail presence and margins. * **Florida Adult-Use Referendum in 2026** * If passed, it would unlock significant upside from GTII’s existing medical dispensaries in the state. * **Possible Uplisting to NASDAQ** * A future listing would boost visibility, enhance credibility, and open access to institutional capital.

martyd94

I've been nibbling on GTII under 9 bucks all the way down to like 6.8 I think was my lowest buy. Only about 300 shares but I sold those today at 8.80. Still got over 2k shares im bag holding. So I'll just play with that I guess. If I goes back down I'll just accumulate more shares.

Den923

Nice trend upwards for the best - **Strong Fundamentals Amid Market Lows** * GTII stands out in a struggling cannabis sector due to its solid financial health and strategic growth initiatives. * **Operational Efficiency & Market Expansion** * Demonstrates strong performance through disciplined operations and a growing footprint across multiple states. * Actively diversifying into new product categories, strengthening long-term growth potential. * **Attractive Acquisition Target with Independent Strength** * Seen as a prime takeover candidate, yet its standalone prospects remain compelling—especially for investors willing to tolerate risk. * **Regulatory Tailwinds Enhance Outlook** * DEA likely to reschedule cannabis to Schedule III in 2025, reducing tax burdens (notably 280E) and increasing MSO profitability. * Expected reintroduction of the SAFER Banking Act, States Reform Act, and STATES 2.0 Act in 2025 could improve banking access and federal legitimacy for cannabis operators. * New hemp regulations may suppress illicit competition, benefiting compliant players like GTII. * **Strategic Partnerships Accelerate Growth** * A potential co-location deal with Alimentation Couche-Tard (7-Eleven) could significantly expand GTII’s retail presence and margins. * **Florida Adult-Use Referendum in 2026** * If passed, it would unlock significant upside from GTII’s existing medical dispensaries in the state. * **Possible Uplisting to NASDAQ** * A future listing would boost visibility, enhance credibility, and open access to institutional capital.

Den923

**May be number two and Green Thumb number 1 .** **Green Thumb Industries (GTII) – Investment Highlights** * **Strong Fundamentals Amid Market Lows** * GTII stands out in a struggling cannabis sector due to its solid financial health and strategic growth initiatives. * **Operational Efficiency & Market Expansion** * Demonstrates strong performance through disciplined operations and a growing footprint across multiple states. * Actively diversifying into new product categories, strengthening long-term growth potential. * **Attractive Acquisition Target with Independent Strength** * Seen as a prime takeover candidate, yet its standalone prospects remain compelling—especially for investors willing to tolerate risk. * **Regulatory Tailwinds Enhance Outlook** * DEA likely to reschedule cannabis to Schedule III in 2025, reducing tax burdens (notably 280E) and increasing MSO profitability. * Expected reintroduction of the SAFER Banking Act, States Reform Act, and STATES 2.0 Act in 2025 could improve banking access and federal legitimacy for cannabis operators. * New hemp regulations may suppress illicit competition, benefiting compliant players like GTII. * **Strategic Partnerships Accelerate Growth** * A potential co-location deal with Alimentation Couche-Tard (7-Eleven) could significantly expand GTII’s retail presence and margins. * **Florida Adult-Use Referendum in 2026** * If passed, it would unlock significant upside from GTII’s existing medical dispensaries in the state. * **Possible Uplisting to NASDAQ** * A future listing would boost visibility, enhance credibility, and open access to institutional capital. **Summary:** GTII combines strong internal execution with powerful external tailwinds. Its strategic positioning, coupled with potential regulatory breakthroughs and expansion opportunities, make it a standout in the cannabis space with high growth potential.

OwnPomegranate1932

The amount of TRUL I've bought \~$5 and GTII \~$7 and CURA \~$1 is going to either make me rich asf or broke asf

martyd94

Jesus... i think im at like 13k... but I'm not letting go! Keep buying GTII when I can.

OwnPomegranate1932

Well I was waiting for $5 [TRUL.CN](http://TRUL.CN) but based on how weak we are, I think I shall wait till $4.50. Added a ton of $GTII.CN yesterday at $6.98 and TSND 2 days ago at 0.385 and already down.

Cool_Ad_5101

that’s what I am hoping for. I insulated my cannabis as only a certain percentage of total, and mostly GTII and truleive with a minimal cresco

Cool_Ad_5101

Agreed. GTII is the only investment here. Trulieve is second if you want risk. Other than that I wouldn’t bother 

Alert-Athlete

I’m hoping the US votes a democratic president in the next election. Then I’d throw money at cannabis (GTII, MSOS are the 2 I have my eyes on).